© 2015

Assessment of Preclinical Organ Damage in Hypertension

  • Enrico Agabiti Rosei
  • Giuseppe Mancia

Table of contents

  1. Front Matter
    Pages i-viii
  2. Heart

    1. Front Matter
      Pages 1-1
    2. Anders M. Greve, Peter M. Okin, Michael Hecht Olsen, Kristian Wachtell
      Pages 3-12
    3. Enrico Agabiti Rosei, Maria Lorenza Muiesan
      Pages 13-24
    4. Athanasios J. Manolis, Eftichia Chamodraka, Ioanna Zacharopoulou
      Pages 25-37
  3. Large Arteries

    1. Front Matter
      Pages 39-39
    2. Enrico Agabiti Rosei, Massimo Salvetti, Maria Lorenza Muiesan
      Pages 41-50
    3. Stéphane Laurent, Pierre Boutouyrie
      Pages 63-73
    4. Denis L. Clement
      Pages 75-79
    5. Isabel Gonçalves, Nuno V. Dias, Peter M. Nilsson
      Pages 81-95
    6. Nuno V. Dias, Isabel Gonçalves, Peter M. Nilsson
      Pages 97-114
  4. Small Arteries

    1. Front Matter
      Pages 115-115
    2. Enrico Agabiti Rosei, Damiano Rizzoni
      Pages 117-126
    3. Christian Ott, Roland E. Schmieder
      Pages 127-142
    4. Enrico Agabiti Rosei, Carolina De Ciuceis, Damiano Rizzoni
      Pages 143-149
    5. Damiano Rizzoni, Claudia Agabiti Rosei
      Pages 151-156
  5. Kidney

    1. Front Matter
      Pages 157-157
    2. Josep Redon, Gernot Pichler, Fernando Martinez
      Pages 159-164
    3. Josep Redon, Gernot Pichler, Fernando Martinez
      Pages 165-170

About this book


This book presents up-to-date information on how to assess early preclinical alterations in the heart, the small and large arteries and the kidney in the general and the hypertensive population, using the most sensitive, specific and cost-effective techniques. A wide variety of techniques are discussed, with careful attention to the latest developments. For each organ, evidence is documented regarding the prevalence of organ damage. Information is provided on the potential induction of regression of organ damage by treatment, the criteria for establishing significant changes and the clinical prognostic significance of regression. The manual will be invaluable for all practitioners responsible for the clinical management of hypertensive patients, given that the assessment of early preclinical cardiovascular and renal damage permits more accurate risk stratification at baseline and facilitates evaluation of cardiovascular protection when regression of structural changes is achieved during treatment.


Atherosclerosis Cardiovascular/renal structural changes Hypertensive population Left ventricular hypertrophy Preclinical heart alterations

Editors and affiliations

  • Enrico Agabiti Rosei
    • 1
  • Giuseppe Mancia
    • 2
  1. 1.Department of Clinical and Experimental SciencesUniversity of BresciaBresciaItaly
  2. 2.IRCCS Istituto Auxologico ItalianoUniversity of Milano-BicoccaMilanoItaly

Bibliographic information

  • Book Title Assessment of Preclinical Organ Damage in Hypertension
  • Editors Enrico Agabiti Rosei
    Giuseppe Mancia
  • DOI
  • Copyright Information Springer International Publishing Switzerland 2015
  • Publisher Name Springer, Cham
  • eBook Packages Medicine Medicine (R0)
  • Hardcover ISBN 978-3-319-15602-6
  • Softcover ISBN 978-3-319-35892-5
  • eBook ISBN 978-3-319-15603-3
  • Edition Number 1
  • Number of Pages VIII, 218
  • Number of Illustrations 16 b/w illustrations, 28 illustrations in colour
  • Topics Cardiology
    Health Promotion and Disease Prevention
  • Buy this book on publisher's site
Industry Sectors
Health & Hospitals
Internal Medicine & Dermatology